Search

Pontevia

Pontevia

galcanezumab

Manufacturer:

Eli Lilly

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Galcanezumab
Indications/Uses
Migraine prophylaxis in adults who have at least 4 migraine days mthly.
Click to view Pontevia detailed prescribing information
Dosage/Direction for Use
Initially 240 mg SC inj as loading dose then 120 mg SC inj once mthly.
Click to view Pontevia detailed prescribing information
Overdosage
View Pontevia overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Pontevia detailed prescribing information
Special Precautions
Discontinue use if serious hypersensitivity reaction occurs. Not to be inj in tender, bruised, red or hardened skin. Immunogenicity. May affect ability to drive & use machines. Pregnancy & lactation. Childn 6-18 yr.
Click to view Pontevia detailed prescribing information
Adverse Reactions
Inj site reactions eg, pain, erythema, pruritus.
Click to view Pontevia detailed prescribing information
Storage
View Pontevia storage conditions for details to ensure optimal shelf-life.
Description
View Pontevia description for details of the chemical structure and excipients (inactive components).
Action
View Pontevia mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD02 - galcanezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Patient Counseling Information
View Pontevia patient counselling information
Presentation/Packing
Form
Pontevia soln for inj 120 mg/mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in